TXNM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
BUY now. TXNM is pulling back into a defined support zone (around 58.83–58.65) while its broader trend remains constructive (SMA_5 > SMA_20 > SMA_200) and options positioning is notably bullish (put/call OI 0.29 with no put volume today). For an impatient buyer, the current post-market price (~58.92) offers a reasonable entry near support with a near-term rebound setup back toward the 59.13 pivot and 59.43–59.61 resistance area.
Trend is still bullish on moving averages (SMA_5 > SMA_20 > SMA_200), suggesting the larger structure is up. However, momentum has weakened short-term: MACD histogram is negative (-0.0447) and expanding lower, indicating the pullback may not be fully finished yet. RSI_6 at 26.5 is oversold/near-oversold, which often supports a bounce attempt. Key levels: price (~58.92) is just below the pivot (59.128) and sitting just above S1 (58.83); if sellers push through, S2 is ~58.646. Upside levels to watch on a bounce: 59.13 (pivot), then 59.43 (R1) and 59.61 (R2). Pattern-based projection provided suggests mild next-day weakness (-0.55%) but stronger 1-week (+4.91%) and 1-month (+27.78%) bias, which aligns with a dip-then-rebound setup.
Intellectia Proprietary Trading Signals
Hedge funds are buying aggressively (buying amount up ~439.58% QoQ), which is a meaningful sentiment tailwind. Technical structure remains bullish on moving averages despite the current dip. Options open interest positioning is call-heavy (bullish skew). Next scheduled catalyst is earnings on 2026-02-23 (pre-market), which can attract positioning ahead of the event. Revenue growth is strong in the latest reported quarter (2025/Q3 +13.69% YoY).
Short-term momentum is deteriorating (negative, expanding MACD histogram), increasing the chance of one more push lower toward ~58.65 support. Profitability trends were weaker in the latest quarter: EPS fell -15.86% YoY and net income was slightly down (-0.37% YoY), which can cap upside until margins/earnings quality improve. No news flow in the last week means fewer immediate event-driven catalysts. Insiders are neutral and there is no supportive insider-buying trend noted.
Latest quarter: 2025/Q3. Revenue rose to $647.162M (+13.69% YoY), indicating solid top-line growth. Net income was essentially flat/slightly down at $130.710M (-0.37% YoY), while EPS declined to $1.22 (-15.86% YoY), implying margin pressure, higher costs, or share count/one-time impacts weighing on per-share profitability even as sales grew.
No analyst rating or price-target change data was provided, so a clear Wall Street consensus trend (upgrades/downgrades and target revisions) cannot be verified from the dataset. Based on available inputs only, the ‘pros’ case is improving revenue and institutional (hedge fund) accumulation; the ‘cons’ case is declining EPS and weakening short-term momentum.
